City of Hope and Osel Announce Exclusive License for Intellectual Property on the Use of Live Biotherapeutic Product CBM588 for Oncology Therapeutic Applications

DUARTE, Calif. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--City of Hope grants Osel exclusive worldwide license for IP on novel use of live biotherapeutic product to enhance efficacy of checkpoint inhibitors.

Click to view original post